Aakaar Medical Technologies Reports Strong H1 FY27 Performance and Operational Turnaround
Aakaar Medical Technologies Ltd · Transcript · 02 Nov 2026, 7:55 pm
Aakaar Medical Technologies Reports Strong H1 FY27 Performance and Operational Turnaround Aakaar Medical Technologies posted revenue from operations of INR43.72 crore for H1 FY27, up 72.64% YoY from INR25.3 crore in Sep'25, with PAT turning around to INR3.54 crore against a loss of INR0.8 crore. EBITDA reached INR5.59 crore with a 12.71% margin, while gross margins stood at 51.39%. Management transitioned to a distributor-led model, appointing over 40 distributors to compress debtor days from 219 days to 130–150 days. The company targets 30%+ revenue CAGR, aiming for mainboard migration within three years.
Original exchange filing (PDF)
More announcements from Aakaar Medical Technologies Ltd
- Aakaar Medical Technologies Limited has informed the Exchange about the Publication Of Notice Of Postal Ballot and Remote E-Voting · 05 Nov 2026
- Aakaar Medical Technologies Limited has informed the Exchange about the Intimation Of Postal Ballot Notice sent to Shareholders. · 04 Nov 2026
- Aakaar Medical Technologies Limited has informed the Exchange about Link of Recording · 31 Oct 2026
- Aakaar Medical Technologies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 31 Oct 2026
- Aakaar Medical Technologies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 30 Oct 2026
- Aakaar Medical Technologies Limited has informed the Exchange about Investor Presentation · 30 Oct 2026
- Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet · 30 Oct 2026
- AAKAAR MEDICAL TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and ESOP. · 30 Oct 2026
